CRYOPORT, INC. Proceeds from Issuance of Private Placement
CRYOPORT, INC. (CYRX) reported Proceeds from Issuance of Private Placement of $37.90 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2025-03-07
- CRYOPORT, INC. proceeds from issuance of private placement for the quarter ending 2023-03-31 was $37.90M.
- CRYOPORT, INC. proceeds from issuance of private placement for the quarter ending 2022-12-31 was $4.60M.
- CRYOPORT, INC. proceeds from issuance of private placement for the quarter ending 2022-09-30 was $0.00.
- CRYOPORT, INC. proceeds from issuance of private placement for the quarter ending 2010-12-31 was $453.38K.
- CRYOPORT, INC. proceeds from issuance of private placement for fiscal 2022 was $37.90M.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2023-03-31 | $37.90M 10-Q · filed 2023-05-04 | $42.50M derived: sum of 2 quarters · filed 2025-03-07 | $42.50M derived: sum of 3 quarters · filed 2025-03-07 | |
| 2022-12-31 | $4.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $4.60M derived: sum of 2 quarters · filed 2025-03-07 | $37.90M 10-K · filed 2025-03-07 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $33.30M 10-Q · filed 2022-11-04 | ||
| 2022-06-30 | $33.30M 10-Q · filed 2022-08-04 | |||
| 2010-12-31 | $453.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-21 | $3.48M 10-Q · filed 2012-02-21 | ||
| 2010-09-30 | $3.03M 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |